Serotonin antagonism

Serotonin antagonism involves the use of drugs that block serotonin receptors, often utilized to address conditions believed to be influenced by excessive serotonin activity.

1. Clinical Trials and Fibrosis: Clinical trials with selective serotonin antagonists, such as terguride, have shown promise in treating conditions linked to elevated serotonin. These antagonists, like the serotonin receptor 5-HT2B antagonist, can have a significant impact on reducing fibrotic states in organs such as the heart, lungs, and kidneys 1.

2. Psychosis and Schizophrenia Treatment: Emerging evidence suggests that high levels of serotonin may contribute to psychosis and schizophrenia. Antagonists targeting serotonin receptors have been effective in clinical trials, showing potential in remission of these conditions. This challenges the traditional focus on dopamine 2.

3. Antidepressant Mechanisms: Some popular antidepressants marketed as SSRIs, like Prozac (fluoxetine), also act as partial serotonin antagonists. Prozac, specifically, is a strong antagonist at the 5-HT2C receptor, which helps in managing cortisol levels but simultaneously increases extracellular serotonin, leading to other systemic effects 3 1.

   • 

     1

     Serotonin Antagonists

     01:28:12
   • 

     2

     Serotonin and Psychosis

     01:36:22
   • 

     3

     Antidepressant Medications

     01:29:58
   • 

     4

     Trazodone and Psychedelics

     02:43:31
     

4. Potential in Psychedelic Intervention: Serotonin type 2A antagonists, such as trazodone, are being explored for their potential to counteract adverse psychedelic experiences. Further research is needed to understand the strength and utility of such drugs in managing psychedelic trips safely 4.

Overall, serotonin antagonism is a complex area with significant implications for treating various conditions, from fibrosis to mental health disorders.